These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 25720991)

  • 1. The effect of disease-modifying antirheumatic drugs on retinal function in the electrophysiological ex vivo model of the isolated perfused vertebrate retina.
    Ranjbar M; Schneider T; Brand C; Grisanti S; Lüke J; Lüke M
    Ophthalmic Res; 2015; 53(3):136-40. PubMed ID: 25720991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The concentration-dependent effects of indocyanine green on retinal function in the electrophysiological ex vivo model of isolated perfused vertebrate retina.
    Ranjbar M; Alt A; Nassar K; Reinsberg M; Schneider T; Grisanti S; Lüke J; Lüke M
    Ophthalmic Res; 2014; 51(3):167-71. PubMed ID: 24642512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of ranibizumab (Lucentis) on retinal function in isolated perfused vertebrate retina.
    Lüke M; Januschowski K; Lüke J; Peters S; Wirtz N; Yörük E; Lüke C; Bartz-Schmidt KU; Grisanti S; Szurman P
    Br J Ophthalmol; 2009 Oct; 93(10):1396-400. PubMed ID: 19628500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of bevacizumab (Avastin®) on the electroretinogram of isolated rat retina.
    Cia D; Cluzel J; Jacquemot N; Doly M
    Ophthalmic Res; 2011; 46(3):145-51. PubMed ID: 21372616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of bevacizumab on retinal function in isolated vertebrate retina.
    Lüke M; Warga M; Ziemssen F; Gelisken F; Grisanti S; Schneider T; Lüke C; Partsch M; Bartz-Schmidt KU; Szurman P;
    Br J Ophthalmol; 2006 Sep; 90(9):1178-82. PubMed ID: 16754646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of triamcinolone crystals on retinal function in a model of isolated perfused vertebrate retina.
    Lüke M; Januschowski K; Beutel J; Warga M; Grisanti S; Peters S; Schneider T; Lüke C; Bartz-Schmidt KU; Szurman P
    Exp Eye Res; 2008 Jul; 87(1):22-9. PubMed ID: 18514644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological toxicity testing of VEGF Trap-Eye in an isolated perfused vertebrate retina organ culture model.
    Januschowski K; Schnichels S; Hagemann U; Koch V; Hofmann J; Spitzer MS; Bartz-Schmidt KU; Szurman P; Lüke M; Aisenbrey S
    Acta Ophthalmol; 2014 Jun; 92(4):e305-11. PubMed ID: 24206925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological effects of Brilliant Blue G in the model of the isolated perfused vertebrate retina.
    Lüke M; Januschowski K; Beutel J; Lüke C; Grisanti S; Peters S; Jaissle GB; Bartz-Schmidt KU; Szurman P
    Graefes Arch Clin Exp Ophthalmol; 2008 Jun; 246(6):817-22. PubMed ID: 18197412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pegaptanib sodium on retinal function in isolated perfused vertebrate retina.
    Lüke M; Januschowski K; Tura A; Lüke J; Nassar K; Lüke C; Schneider T; Szurman P; Grisanti S; Bartz-Schmidt KU
    Curr Eye Res; 2010 Mar; 35(3):248-54. PubMed ID: 20373885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the effects of two different irrigation solutions on an isolated perfused vertebrate retina.
    Januschowski K; Maddani R; Mueller S; Lueke M; Spitzer MS; Schultheiss M; Bartz-Schmidt KU; Szurman P
    Ophthalmic Res; 2012; 48(2):59-66. PubMed ID: 22472946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of protein tyrosine kinase inhibitor genistein on retinal function in superfused vertebrate retina.
    Lüke C; Krott R; Lüke M; Lebek J; Walter P; Brunner R; Sickel W
    J Ocul Pharmacol Ther; 2001 Apr; 17(2):151-8. PubMed ID: 11324982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety profile of alkylphosphocholines in the model of the isolated perfused vertebrate retina.
    Lüke M; Januschowski K; Lüke J; Grisanti S; Szurman P; Dietz K; Kampik A; Bartz-Schmidt KU; Eibl-Lindner KH
    Graefes Arch Clin Exp Ophthalmol; 2010 Apr; 248(4):511-8. PubMed ID: 20091176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating short-term toxicity of melphalan in a model of an isolated and superfused bovine retina.
    Januschowski K; Krupp C; Mueller S; Hofmann K; Schnichels S; Hagemann U; Spitzer MS; Bartz-Schmidt KU; Aisenbrey S
    Graefes Arch Clin Exp Ophthalmol; 2016 Jan; 254(1):91-6. PubMed ID: 26335534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating retinal toxicity of tempol in a model of isolated and perfused bovine retina.
    Januschowski K; Mueller S; Dollinger R; Schnichels S; Hofmann J; Spitzer MS; Bartz-Schmidt KU; Szurman P; Thaler S
    Graefes Arch Clin Exp Ophthalmol; 2014 Jun; 252(6):935-41. PubMed ID: 24789463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The retinal biocompatibility of dyes in the ex vivo model of the isolated superfused vertebrate retina.
    Lüke M; Grisanti S; Lüke J;
    Ophthalmologica; 2013; 230 Suppl 2():21-6. PubMed ID: 24022715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Symmons DP; Watson KD; Silman AJ;
    Arthritis Rheum; 2006 Jun; 54(6):1786-94. PubMed ID: 16736520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonists of ionotropic gamma-aminobutyric acid receptors impair the NiCl2-mediated stimulation of the electroretinogram b-wave amplitude from the isolated superfused vertebrate retina.
    Siapich SA; Banat M; Albanna W; Hescheler J; Lüke M; Schneider T
    Acta Ophthalmol; 2009 Nov; 87(8):854-65. PubMed ID: 20002018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity and retinal penetration of infliximab in primates.
    Melo GB; Moraes Filho MN; Rodrigues EB; Regatieri CV; Dreyfuss JL; Penha FM; Pinheiro MM; Coimbra RC; Haapalainen EF; Farah ME
    Retina; 2012 Mar; 32(3):606-12. PubMed ID: 22080907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The retinal tolerance to bevacizumab in co-application with a recombinant tissue plasminogen activator.
    Lüke M; Januschowski K; Warga M; Beutel J; Leitritz M; Gelisken F; Grisanti S; Schneider T; Lüke C; Bartz-Schmidt KU; Szurman P;
    Br J Ophthalmol; 2007 Aug; 91(8):1077-82. PubMed ID: 17383998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing the biocompatibility of a glutathione-containing intra-ocular irrigation solution by using an isolated perfused bovine retina organ culture model - an alternative to animal testing.
    Januschowski K; Zhour A; Lee A; Maddani R; Mueller S; Spitzer MS; Schnichels S; Schultheiss M; Doycheva D; Bartz-Schmidt KU; Szurman P
    Altern Lab Anim; 2012 Mar; 40(1):23-32. PubMed ID: 22558975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.